Cargando…
HER2 reduces breast cancer radiosensitivity by activating focal adhesion kinase in vitro and in vivo
Growing evidence has demonstrated that human epidermal growth factor receptor 2 (HER2) is involved in the radiation response to breast cancer. However, the underlying mechanism remains elusive. Therefore, we investigated if HER2 overexpression is associated with radiosensitivity of breast cancer. We...
Autores principales: | Hou, Jing, Zhou, Zhirui, Chen, Xingxing, Zhao, Ruping, Yang, Zhaozhi, Wei, Na, Ni, Qing, Feng, Yan, Yu, Xiaoli, Ma, Jinli, Guo, Xiaomao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216715/ https://www.ncbi.nlm.nih.gov/pubmed/27286256 http://dx.doi.org/10.18632/oncotarget.9870 |
Ejemplares similares
-
CDK4/6 inhibitors: a novel strategy for tumor radiosensitization
por: Yang, Yilan, et al.
Publicado: (2020) -
Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells
por: Chen, Xingxing, et al.
Publicado: (2017) -
Intraoperative Radiotherapy Versus Whole-Breast External Beam Radiotherapy in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Li, et al.
Publicado: (2015) -
Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients
por: Wang, Jiangfeng, et al.
Publicado: (2020) -
Multibeam inverse intensity-modulated radiotherapy (IMRT) for whole breast irradiation: a single center experience in China
por: Yang, Zhaozhi, et al.
Publicado: (2015)